Oncological drugs take more than two and a half years to reach patients

A new analysis covering 2020-2025 data shows that innovative cancer drugs take an average of 926 days to reach patients in Portugal after European approval, significantly longer than the EU average of 655 days. The report also highlights that over half of surveyed patients (50.8%) have experienced at least one instance of being without medication due to stock shortages, and patients travel an average of 56 kilometers to access their treatment.